Two thyroid cancer patients who received lenvatinib
نویسندگان
چکیده
منابع مشابه
Lenvatinib for Anaplastic Thyroid Cancer
BACKGROUND Lenvatinib has been approved by regulatory agencies in Japan, the United States, and the European Union for treatment of radioiodine-refractory differentiated thyroid cancer (RR-DTC). Thyroid cancer, however, is a clinically diverse disease that includes anaplastic thyroid cancer (ATC), the subtype associated with the highest lethality. Effective therapy for ATC is an unmet need. P...
متن کاملhematologic toxicities in colorectal cancer patients who received folfox4
background: over the past decade, survival from advanced colorectal cancer is increasing. therefore patients have more exposure to chemotherapy and related toxicities. this study determines how hematologic toxicity patterns affect therapy and care. methods: from april 2010 to march 2013, we enrolled 127 patients with stages iib to iv colorectal cancer. patients underwent complete blood count mo...
متن کاملEfficacy of lenvatinib in a patient with anaplastic thyroid cancer
We experienced a case of an 82-year-old woman who presented to our hospital with a 1-month history of dysphagia and dyspnea. Cervical contrast-enhanced computed tomography revealed diffuse thyroid neoplasms causing significant tracheal stenosis with tumors, particularly of the superior mediastinum, which were associated with an embolism of the brachiocephalic vein and suspected invasion to the ...
متن کاملClinical features of lenvatinib treatment in elderly patients with advanced thyroid cancer
Until recently, there had not been an effective systemic chemotherapy for advanced differentiated thyroid carcinoma (DTC); lenvatinib, a multi-tyrosine kinase inhibitor, has been proven effective for DTC, but has also been revealed to have adverse side effects including hypertension, hand-foot syndrome (HFS) and diarrhea. There have been few clinical studies focused on the characteristics, safe...
متن کاملSynovial sarcoma of the lung in a patient who received radioactive iodine therapy for thyroid cancer.
BACKGROUND Synovial sarcomas are uncommon malignancies that mainly affect adolescents and young adults. Most arise from the deep soft tissues of the extremities, but they can occur in other parts of the body such as the lung. Synovial sarcomas after radiation therapy are rare, in contrast with other sarcomas, with only six reported cases. Secondary malignancies after radioactive iodine (RAI) th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
سال: 2016
ISSN: 1349-581X,1884-474X
DOI: 10.5106/jjshns.26.259